CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-11 | Lawrence Bryan Jay Director | Grant or award · Stock Option (right to Buy) | +5,000 | 5,000 | ||
| 2024-06-11 | Lawrence Bryan Jay Director | Grant or award · Stock Option (right to Buy) | +14,125 | 14,125 | ||
| 2024-06-11 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +63,324 | 63,324 | ||
| 2024-06-11 | Ervin Jeffrey S Director | Grant or award · Stock Option (right to Buy) | +5,000 | 5,000 | ||
| 2024-06-11 | Ervin Jeffrey S Director | Grant or award · Stock Option (right to Buy) | +13,875 | 13,875 | ||
| 2024-04-11 | Werth Peter J. Director | Option exercise | +341,912 | $0.00 | $684 | 481,829 |
| 2024-04-11 | Werth Peter J. Director | Option exercise | +694,096 | $0.00 | $69 | 1,175,925 |
| 2024-04-11 | Werth Peter J. Director | Option exercise · Pre-Funded Warrant (right to buy) | −341,912 | 0 | ||
| 2024-04-11 | Werth Peter J. Director | Option exercise · Pre-Funded Warrant (right to buy) | −694,096 | 0 | ||
| 2024-03-29 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +1,000 | 1,000 | ||
| 2024-03-29 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +1,000 | 1,000 | ||
| 2024-03-25 | Werth Peter J. Director | Other acquisition · Pre-Funded Warrant (right to buy) | +7,053 | 694,096 | ||
| 2024-03-04 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +16,676 | 16,676 | ||
| 2024-03-04 | Schaffer Shane J. Chief Executive Officer | Grant or award · Stock Option (right to Buy) | +57,323 | 57,323 | ||
| 2024-03-04 | ROBERTS JOHN A Director | Grant or award · Stock Option (right to Buy) | +5,000 | 5,000 | ||
| 2024-03-04 | Werth Peter J. Director | Grant or award · Stock Option (right to Buy) | +1,824 | 1,824 | ||
| 2024-03-04 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +16,676 | 16,676 | ||
| 2024-03-04 | Myers Laurie EVP and COO | Grant or award · Stock Option (right to Buy) | +26,056 | 26,056 | ||
| 2024-03-04 | Ervin Jeffrey S Director | Grant or award · Stock Option (right to Buy) | +5,000 | 5,000 | ||
| 2024-03-04 | Callahan Jennifer L. SVP and CFO | Grant or award · Stock Option (right to Buy) | +25,014 | 25,014 |
Page 5 of 11 · 202 trades